Study S001206

Regulation of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide (Victoza)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02201550
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 9
Start: 2013-02
Primary completion: 2014-04
Lead sponsor: Hvidovre University Hospital
Conditions: Type 2 Diabetes Mellitus
Results posted: FALSE

Registered primary outcomes

Change in number of specific immune cells in blood detected by flow cytometry [Before and 12 weeks after initiation of liraglutide treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.